| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e31bc510b3ef35148ec0b929c3c27c2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291feea8508ba4fce589059e70eb681c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6000ab2117d057013d909c31d623b9a |
| publicationDate |
2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7037500-B1 |
| titleOfInvention |
Method for using phagocytic particles and ATP receptors to deliver antigens to MHC class I receptors to induce immunity against microbial pathogens or tumors or to suppress immunity |
| abstract |
This invention provides methods of delivering an antigen to an Class I or Class II MHC receptors to induce immunity against the antigen in a subject having a disease. This invention also provides methods of delivering an antigen to an Class II or class I MHC receptor to supress immunity against the antigen in a subject having a disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2919804-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100075832-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101873862-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008285595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9950049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016196517-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535744-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018344822-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009019317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11613759-B2 |
| priorityDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |